Articles from: Medical news (Moreover)
 |
|
|
| Next Page
| |
| Diagnosis, prevention and treatment of postoperative Crohns disease recurre (more) | 2012 01 30 |
|
| First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Sin (more) | 2012 01 30 |
|
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
|
|
| Study shows Takeda's diabetes drug increases bladder cancer risk (more) | 2012 01 30 |
|
| New mechanism of drug release using 3D superhydrophobic materials (more) | 2012 01 30 |
|
| Fear-Resistance: How Worried Should We Be about 'Totally Drug-Resistant' Tu (more) | 2012 01 30 |
|
|
|
|
| A randomized phase-II trial comparing sequential and concurrent paclitaxel (more) | 2012 01 30 |
|
| Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metasta (more) | 2012 01 30 |
|
|
| Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progres (more) | 2012 01 30 |
|
|
|
| Blood sugar self-monitoring has no benefit for diabetics not on insulin (more) | 2012 01 30 |
|
|
| Intraoperative Detection of Disappearing Colorectal Liver Metastases as a P (more) | 2012 01 30 |
|
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
| Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepato (more) | 2012 01 30 |
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
|
| Reappraisal of Hepatopancreatoduodenectomy as a Treatment Modality for Bile (more) | 2012 01 30 |
|
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
| Viewpoints: Health law's consumer safeguards; Shredding Medicare's safety n (more) | 2012 01 30 |
|
| Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases (more) | 2012 01 30 |
|
|
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
|
|
| Cell Therapeutics Pulls Cancer Drug After CEO Boasted About Approval Chance (more) | 2012 01 30 |
|
| US professor discoveries prostate cancer in 2,200-year-old mummy (more) | 2012 01 30 |
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
| Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clin (more) | 2012 01 30 |
|
|
| Phase I first-in-human study of TAK-285, a novel investigational dual HER2/ (more) | 2012 01 30 |
|
|
| Bevacizumab added to neoadjuvant chemotherapy for breast cancer (more) | 2012 01 30 |
|
| Why do results conflict regarding the prognostic value of the methylation s (more) | 2012 01 30 |
|
| open access: Upper abdominal cytoreduction and thoracoscopy for advanced ep (more) | 2012 01 30 |
|
| Disruption of CTCF at the miR-125b1 locus in gynecological cancers (more) | 2012 01 30 |
|
| Risk factors associated with fatal pulmonary hemorrhage in locally advanced (more) | 2012 01 30 |
|
| Next Page
| |